JPMorgan Chase & Co’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.9M | Buy |
867,373
+300,046
| +53% | +$4.8M | ﹤0.01% | 1973 |
|
|
2025
Q1 | $11M | Buy |
567,327
+235,662
| +71% | +$4.58M | ﹤0.01% | 2112 |
|
|
2024
Q4 | $7.31M | Sell |
331,665
-95,990
| -22% | -$2.11M | ﹤0.01% | 2487 |
|
|
2024
Q3 | $7.2M | Buy |
427,655
+75,092
| +21% | +$1.26M | ﹤0.01% | 2395 |
|
|
2024
Q2 | $4.21M | Buy |
352,563
+120,519
| +52% | +$1.44M | ﹤0.01% | 2623 |
|
|
2024
Q1 | $2.57M | Buy |
232,044
+36,348
| +19% | +$403K | ﹤0.01% | 2990 |
|
|
2023
Q4 | $1.69M | Buy |
195,696
+73,957
| +61% | +$640K | ﹤0.01% | 3236 |
|
|
2023
Q3 | $931K | Buy |
121,739
+66,196
| +119% | +$506K | ﹤0.01% | 3439 |
|
|
2023
Q2 | $400K | Sell |
55,543
-28,470
| -34% | -$205K | ﹤0.01% | 3880 |
|
|
2023
Q1 | $512K | Buy |
84,013
+18,435
| +28% | +$112K | ﹤0.01% | 3814 |
|
|
2022
Q4 | $286K | Buy |
65,578
+9,162
| +16% | +$40K | ﹤0.01% | 4044 |
|
|
2022
Q3 | $221K | Sell |
56,416
-2,476
| -4% | -$9.7K | ﹤0.01% | 4127 |
|
|
2022
Q2 | $301K | Buy |
58,892
+9,393
| +19% | +$48K | ﹤0.01% | 4131 |
|
|
2022
Q1 | $317K | Buy |
49,499
+30,410
| +159% | +$195K | ﹤0.01% | 4221 |
|
|
2021
Q4 | $153K | Buy |
19,089
+5,664
| +42% | +$45.4K | ﹤0.01% | 4659 |
|
|
2021
Q3 | $124K | Buy |
+13,425
| New | +$124K | ﹤0.01% | 4619 |
|